Filtros de búsqueda

Lista de obras de

90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas

artículo científico publicado en 2014

A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials.

artículo científico publicado en 2014

Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study.

artículo científico publicado en 2011

Benefit, burden, and impact for a cohort of post-approval cancer combination trials

artículo científico publicado en 2019

Comparison between protocols and publications for prognostic and predictive cancer biomarker studies

artículo científico publicado en 2019

Design of a Physical Activity Program to Prevent Functional Decline in Onco-Geriatric Patients (CAPADOGE): A Randomized Multicenter Trial

artículo científico publicado en 2012

Design of placebo-controlled randomized trials of anticancer agents: Ethical considerations based on a review of published trials

artículo científico publicado en 2021

Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions.

artículo científico publicado en 2015

Dose finding methods for targeted agents: new perspectives

artículo científico publicado en 2010

Dose-finding design using mixed-effect proportional odds model for longitudinal graded toxicity data in phase I oncology clinical trials.

artículo científico publicado en 2013

Dose-finding designs in pediatric phase I clinical trials: Comparison by simulations in a realistic timeline framework

artículo científico publicado el 13 de abril de 2012

French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patients

artículo científico publicado en 2015

Fresh-frozen plasma transfusion did not reduce 30-day mortality in patients undergoing cardiopulmonary bypass cardiac surgery with excessive bleeding: the PLASMACARD multicenter cohort study

artículo científico publicado en 2013

Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial.

artículo científico publicado en 2012

Impact du statut socioéconomique sur la gravité du diagnostic initial de cancer du sein

artículo científico publicado en 2011

Innovations for phase I dose-finding designs in pediatric oncology clinical trials.

artículo científico publicado en 2016

Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial.

artículo científico publicado en 2014

One-Year Mortality in Older Patients with Cancer: Development and External Validation of an MNA-Based Prognostic Score

artículo científico publicado en 2016

Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials.

artículo científico publicado en 2012

Pseudomonas aeruginosa acquisition on an intensive care unit: relationship between antibiotic selective pressure and patients' environment

artículo científico publicado en 2011

[Psychiatric adverse effects of fluoroquinolone: review of cases from the French pharmacologic surveillance database]

artículo científico publicado en 2006